CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for HPGC Renmintongtai Pharmaceutical Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

HPGC Renmintongtai Pharmaceutical Corp
No. 418, Hayao Road, Daoli District
Phone: +86 45184600888p:+86 45184600888 HAERBIN, HNG  150076  China Ticker: 600829600829
Business Summary
HPGC Renmintongtai Pharmaceutical Corp is a China-based company principally engaged in pharmaceutical wholesale, pharmaceutical retail, medical services, and pharmaceutical logistics businesses. The Company's pharmaceutical wholesale business is operated by its medicine branch and new and special drug branch, mainly providing delivery services for pharmaceuticals, medical devices, and health food through a pure sales model supported by allocation services. The Company's main products include chemical drugs, proprietary Chinese medicines, biological products, medical devices, Chinese herbal pieces, health food, daily necessities, glass instruments, and chemical reagents.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2025Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
5912 Drug stores and proprietary stores
5047 Medical, dental, and hospital equipment and supplies
5032 Brick, stone, and related construction materials
3295 Minerals and earths, ground or otherwise treated
3241 Cement, hydraulic
2833 Medicinal chemicals and botanical products
4729 Arrangement of passenger transportation, not elsewhere classified
6531 Real estate agents and managers
5499 Miscellaneous food stores
3842 Orthopedic, prosthetic, and surgical appliances and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager WeidongZhu 56 3/6/2026 8/2/2016
Finance Director, Deputy General Manager PingGuan 53 4/7/2022 4/7/2022
Deputy General Manager LinaGao 47 5/19/2026 5/19/2026
6 additional Officers and Directors records available in full report.

Business Names
Business Name
600829
Harbin Pharm Group Sanjing Pharm Co Ltd

General Information
Number of Employees: 2,735 (As of 12/31/2025)
Outstanding Shares: 579,888,597 (As of 3/31/2026)
Shareholders: 45,188
Stock Exchange: SHA
Fax Number: +86 45184600888


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 25, 2026